Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2008-01-16

EMA Application withdrawn: Insulin Human Rapid Marvel (human insulin) — Marvel LifeSciences Ltd.

View source ↗

Summary

Application withdrawn for Insulin Human Rapid Marvel (human insulin) by Marvel LifeSciences Ltd. for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Human Rapid Marvel (insulin)

Snippet

Status: Application withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Marvel LifeSciences Ltd.. Decision date: 31/12/2009